BBS-Bioactive Bone Substitutes (OHEL:BONEH) Other Long-Term Liabilities : €0.18 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes Other Long-Term Liabilities?

BBS-Bioactive Bone Substitutes's other long-term liabilities for the quarter that ended in Dec. 2023 was €0.18 Mil.

BBS-Bioactive Bone Substitutes's quarterly other long-term liabilities declined from Dec. 2022 (€0.18 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.18 Mil).

BBS-Bioactive Bone Substitutes's annual other long-term liabilities declined from Dec. 2021 (€0.18 Mil) to Dec. 2022 (€0.18 Mil) but then increased from Dec. 2022 (€0.18 Mil) to Dec. 2023 (€0.18 Mil).

BBS-Bioactive Bone Substitutes Other Long-Term Liabilities Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes Other Long-Term Liabilities Chart

BBS-Bioactive Bone Substitutes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

BBS-Bioactive Bone Substitutes Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial											-	-	-	-	-

BBS-Bioactive Bone Substitutes Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

BBS-Bioactive Bone Substitutes Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiviharjunlenkki 6, Oulu, FIN, 90220

Website

http://www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines